Q2 FY2026 · ended Jun 30, 2026 · Revenue $0 · Filed Aug 14, 2026
BeyondSpring Inc. (BYSI) files with the SEC under industry code 2834, Pharmaceutical Preparations. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $0 and a net loss of $849,000. Free cash flow was -$3.8 million. As of Jun 30, 2026 it held $6.5 million in cash and investments and $171,000 in total debt.
Revenue
$0
Net income
$-849,000
+53.0% vs year-ago quarter
Operating cash flow
$-3.77M
+35.8% vs year-ago quarter
Free cash flow
$-3.77M
+35.8% vs year-ago quarter
EPS
$-0.10
Dividend per share
None
Shares outstanding
41.12M
+2.0% vs year-ago quarter
Net cash
$6.36M
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BYSI (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Florham Park, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1677940
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating income | -$1.7M | -$2.2M | -$2.6M | -$1.8M | -$1.9M |
| Net income | -$849,000 | -$2.2M | -$2.1M | -$1.5M | -$1.8M |
| Diluted EPS | — | — | — | — | -$0.10 |
| Operating cash flow | -$3.8M | -$3.3M | -$5.5M | -$4.2M | -$5.9M |
| Free cash flow | -$3.8M | -$3.3M | -$5.5M | -$4.2M | -$5.9M |
| Total assets | $14.6M | $18.4M | $25.9M | $29.5M | $31.0M |
| Total liabilities | $50.6M | $48.8M | $49.9M | $49.3M | $48.6M |
| Stockholders' equity | -$35.6M | -$34.5M | -$32.2M | -$31.8M | -$30.2M |
| Cash and investments | $6.5M | $7.9M | $12.6M | $12.6M | $9.5M |
| Total debt | $171,000 | $246,000 | $320,000 | $406,000 | $477,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
Oct 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 2, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 18, 2026 | Sep 17, 2026 |
| ARS | Annual report to shareholders | Sep 3, 2026 | Dec 31, 2025 |
All 264 BeyondSpring Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.